ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2013 American Transplant Congress

May 18-22, 2013 in Seattle, Washington

Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
  • Rabbit Antithymocyte Globulin Induction Therapy Induces Donor-Specific HeliosnegFOXP3pos Regulatory T Cells in Kidney Transplant Patients

    A. Bouvy, M. Klepper, M. Kho, J. IJzermans, N. Litjens, M. Betjes, W. Weimar, C. Baan

  • Rabbit ATGs Modulate the Leukocyte-Endothelium Interactions in Both Naïve and Adult Endothelial Cells

    A. Beiras-Fernandez, I. Hartmann, F. Kur, I. Kaczmarek, I. Kanzler

  • Racial and Ethnic Differences in Determinants of Live Donor Kidney Transplantation in the United States

    T. Purnell, P. Xu, N. Leca, Y. Hall

  • Racial Differences and Income Disparities Are Associated with Worse Allograft and Death Outcomes in Kidney Transplant Recipients with Lupus Nephritis

    R. Nee, K. Abbott, D. Little, R. Ramsey-Goldman, L. Agodoa, F. Hurst, R. Jindal

  • Racial Disparities in GRAFT SURVIVAL in the Elderly KIDNEY Transplant Patients

    T. Ilori, R. Patzer, J. Byrd, W. McClellan

  • Racial Variation in Medical Outcomes among Medicare and Privately-Insured Living Kidney Donors

    K. Lentine, D. Segev, D. Axelrod, A. Garg, D. Brennan, J. Tuttle-Newhall, M. Schnitzler

  • Rapamycin and CTLA4-Ig Demonstrate Age-Specific Effects on Transplant Outcome and Immune Responses

    K. Edtinger, A. Elkhal, X. Ge, S. Tullius

  • Rapamycin Enhances Early Alloantibody Production by Hampering the Homeostatic Proliferation of Regulatory T Cells

    B. Oh, J. Kwun, R. Ruhil, A. Gibby, E. Page, A. Farris III, A. Kirk, N. Iwakoshi, S. Knechtle

  • Rapamycin-Induced Augmentation of the CD8 T Cell Response to a Latent Viral Infection Is Inhibited by CTLA4-Ig

    D. Pinelli, M. Wagener, M. Ford

  • Rapamycin-Resistant mTORC1 Regulates Dendritic Cell B7-H1 Expression That Acts in Synergy with IL-1β To Promote Regulatory T Cell Induction

    B. Rosborough, D. Raich-Regue, B. Matta, K. Lee, M. Boothby, H. Turnquist, A. Thomson

  • Rapid Flow-Cytometric Detection of Cell-Mediated Alloreactivity in Transplant Candidates and Healthy Controls

    M. Wolf, S. Kirsch, M. Sester, U. Sester

  • Rat Liver Allo-Graft Rejection Promotes Anti-Cancer Immunity: A Model of Transplantation for Hepatocellular Carcinoma

    S. Lacotte, G. Oldani, L. Rubbia-Brandt, F. Slits, L. Orci, P. Morel, G. Mentha, C. Toso

  • Rate and Causality of Thirty-Day Readmissions Following Renal Transplantation

    M. Watson, D. Goldfarb, V. Krishnamurthi, D. Shoskes, J. Rabets

  • Rates and Outcomes of Renal Transplantation in Children with Intellectual Disability

    A. Wightman, J. Janosko, B. Young, A. Dick, R. McDonald, P. Healey, J. Smith

  • Rates of False Flagging Due to Statistical Artifact in CMS Evaluations of Transplant Programs

    A. Massie, D. Segev

  • Rationale for, and the Economic Implications Associated with, Extending Medicare Coverage for Immunosuppressive Medications to Kidney Transplant Recipients Who Lack Insurance Coverage, The

    R. Evans

  • RBC Transfusions Are Associated with HLA Allosensitization in Patients Awaiting Kidney Transplantation

    B. Bradbury, M. Leffell, D. Kim, J. Petersen, J. Hart, J. Rossert, R. Vega, A. Zachary

  • Re-Wiring the Molecular Circuitry of the AlloGraft To Promote Tolerance

    N. Zammit, S. Walters, J. Villanueava, S. Grey

  • Real-Time Three-Dimensional Fourier-Domain Optical Coherence Tomography for Intravital Imaging of Thrombosis after Vascularized Composite Allotransplantation Procedures

    Q. Mao, Y. Huang, J. Pang, S. Zhu, D. Tong, Z. Ibrahim, J. Christensen, Y. Li, J. Li, W. Lee, J. Kang, G. Brandacher

  • Recipient Death and Graft Loss in Renal Transplantation: The Challenge of Infectious Complications

    M. Cristelli, M. Ivani, F. Pita, F. Ferreira, S. Martins, C. Aldworth, M. Francoso, M. Franco, H. Tedesco, J. Medina- Pestana

  • Recipient Pre-Operative Regulatory T Cell Function: A Predictor of Acute Kidney Injury after Kidney Transplantation

    M. Nguyen, S. Sahakian, E. Fryml, M. Cantarovich, S. Liu, M. Lipman, J. Tchervenkov, S. Paraskevas

  • Recipient’s Conventional Dendritic Cells (DC) Are the Mediators of the Beneficial Effects of Immunosuppressive DC-Based Therapies in Cardiac Transplantation

    Z. Wang, S. Divito, D. Rojas-Canales, W. Shufesky, T. Sumpter, A. Larregina, A. Morelli

  • Recurrence of Focal Segmental Glomerulosclerosis after Renal Transplantation: Who Benefits from Preemptive Plasmapheresis?

    D. Bruley, L. Croze, B. Burroni, N. Pinel, P. Malvezzi, P. Zaoui

  • Reduced Health Literacy in Kidney Transplant Recipients May Be Associated with Difficulty Identifying a Live Kidney Donor

    L. Dageforde, A. Petersen, K. Harms, I. Feurer, J. Ehrenfeld, K. Cavanaugh, D. Moore

  • Reducing HIV / HCV Infection Transmission from Organ Transplantation through Nucleic Acid Testing of All Potential Deceased Donors: A Cost-Effectiveness Analysis

    J. Lai, J. Kahn, M. Tavakol, M. Peters, J. Roberts

  • Reduction in Mycophenolate in Leukopenic Renal Transplant Patients Is Not Associated with Worse Transplant Outcomes at 1 Year and 3 Year Post-Transplant

    M. Kim, A. Chandraker, S. Gabardi

  • Reduction in New Onset Diabetes after Renal Transplant with Erythropoietin Stimulating Agents, a Case Control Study

    T. Montada-Atin, D. Choi, M. Woo, R. Retnakaran, M. Huang, G. Prasad, J. Zaltzman

  • Regulation of microRNA in Ischemia Reperfusion Injury in Heart Transplantation, The

    L. Zhou, N. Johnston, X. Zhang, D. Cheng, L. Sui, P. Luke, A. Jevnikar, W. Min, X. Zheng

  • Regulation of Serological Alloreactive Memory by Pathogen Infection, The

    R. Ruhil, O. Bulut, S. Talebagha, B. Oh, V. Lu, S. Knechtle, N. Iwakoshi

  • Regulatory Dendritic Cells (DCreg) Prolong Kidney Allograft Survival in Non-Human Primates When Combined with Costimulation Blockade and Rapamycin

    M. Ezzelarab, A. Zahorchak, L. Lu, M. Adrian, L. Fadi, J. Demetris, A. Humar, R. Shapiro, N. Murase, M. Wijkstrom, D. Cooper, A. Thomson

  • Regulatory Effect of microRNAs in Ischemia Reperfusion Injury Post Liver Transplantation: Looking for Therapeutic Targets

    R. Gehrau, V. Mas, C. Dumur, J. Suh, M. Wardus, B. Kane, S. Luebbert, D. Maluf

  • Regulatory Molecular Profile of Early Ischemia Reperfusion Injury after Liver Transplantation

    R. Gehrau, V. Mas, C. Dumur, J. Suh, L. Murray, B. Kane, D. Maluf

  • Regulatory T Cell Induction by Soluble Components of a Traditional Chinese Herb

    J. Reid-Adam, P. Cravedi, N. Yang, X. Li, P. Heeger

  • Rejection Phenotypes, Rejection Timing and Kidney Transplant Outcome

    M. Naesens, D. Kuypers, K. De Vusser, Y. Vanrenterghem, E. Lerut

  • Relationship of Kidney Length, Volume and Renal Split Function in Living Kidney Donors

    S. Fernandez, S. Mohan, Z. Zaky, J. Crew, J. Dube, M. Carrol, J. Wexler, L. Ratner, D. Cohen, B. Tanriover

  • Removal of CD39+ T Cells Uncovers a Population of Col V Specific, CD39- Responder T Cells in Normal, Healthy Individuals

    J. Sullivan, S. Hedge, E. Gankowski-Gan, W. Burlingham

  • Renal Allograft Survival of HLA-Identical Living Donors (ID-LDRT) and 6-HLA Matched Cadaveric Donors (6M-CRT) Compared with 5 HLA-Matched Controls

    V. Gunabushanam, R. Nusrat, H. Lam, P. Sood, S. Hariharan, J. Donaldson, A. Humar, M. Wijkstrom

  • Renal Allograft Tolerance Can Be Achieved in Non-Human Primates Via Delayed Mixed-Hematopoietic Chimerism and Alefacept Treatment

    S. Lee, Y. Yamada, S. Boskovic, M. Atif, M. Tonsho, O. Nadazdin, R. Smith, R. Colvin, J. Allan, J. Madsen, A. Cosimi, G. Benichou, T. Kawai

  • Renal Graft Outcome after Single-Donor Staged Heart-Kidney Transplantation Using Pulsatile Machine Perfusion of the Renal Grafts

    A. El Hinnawi, J. Sageshima, G. Ciancio, L. Chen, A. Mattiazzi, G. Guerra, W. Kupin, D. Roth, E. Rosenkranz, A. Panos, S. Pham, G. Burke III

  • Renal Graft Survival among Primary, Re-Transplant, and Kidney after Solid Organ Transplantation: A Single Center Experience

    R. Nusrat, P. Sood, A. Tevar, R. Shapiro, A. Humar, S. Hariharan

  • Renal Graft Survival Post Thoracic and Abdominal Transplant: A Single Center Experience

    R. Nusrat, S. Hariharan, A. Tevar, R. Shapiro, A. Humar, P. Sood

  • Renal Ischemia/Reperfusion Induces Release of Angiopoietin-2 from Human Grafts of Living and Deceased Donors

    M. Reinders, D. de Vries, M. Khairoun, J. Lindeman, I. Bajema, E. de Heer, M. Roest, A. van Zonneveld, C. van Kooten, A. Schaapherder, T. Rabelink

  • Renal Outcomes in Prediabetic Living Kidney Donors Are Very Similar to Normoglycemic Donors at 10 Years Post-Donation

    S. Chandran, U. Masharani, A. Webber, D. Wojciechowski

  • Renal Transplant Recipients (RTR) with Immune Mediated Graft Injury Display Significant Alterations within the Peripheral B Cell Phenotype

    A. Cherukuri, A. Salama, C. Carter, B. Clark, R. Baker

  • Renal Transplant Recipients with Positive Donor Specific Antibodies Maintain Stable Graft Function with Mycophenolic Acid Escalation

    L. Rebellato, P. Bolin, K. Parker, A. Allsbrook, B. Brown, S. Kendrick, M. Everly, P. Terasaki, R. Harland

  • Renal Transplantation with Final Allocation Based on the Virtual Crossmatch: Outcomes at 5 Years

    C. Johnson, Y. Zhu, M. Zhang, B. Shames, A. Roza, D. Cronin, S. Hariharan, J. Schiller, T. Ellis

  • Reperfusion Injury in Extended Criteria Donor Liver Grafts: A Look inside the Molecular Level

    D. Maluf, R. Gehrau, J. Suh, C. Dumur, B. Kane, V. Mas

  • Reperfusion Time Alters Kidney microRNA Expression in Rodent Ischemia-Reperfusion Injury

    T. Merchen, E. Boesen, N. Nahman Jr, R. Podolsky, R. Harbarger, A. Ghaffari, J. Wynn, A. Mellor, D. Pollock

  • Requirement for T Cell Intrinsic MyD88 for Treg Homeostasis in Transplantation

    C. Borges, B. Kim, L. Turka

  • Residual Renal Function in Living Kidney Donors: Does Remaining Kidney Volume Matter?

    A. Diez, C. Sundaram, M. Mujtaba, T. Taber, M. Yaqub, D. Mishler, J. Powelson, W. Goggins, A. Sharfuddin

  • Restoration of Long Nerve Defects with Epineural Sheath Conduit Supported with Bone Marrow Stromal Cells. A Preliminary Report

    M. Madajka, C. Ozturk, M. Lukaszuk, G. Kwiecien, J. Szopinski, V. Siemionow, M. Siemionow

  • Restored Kidney Transplant after Resection of Small Renal Tumor into Unrelated and Related Recipients: Updated Results of Clinical Trials

    Y. Ogawa, T. Kobayashi, S. Shiroma, K. Kojima, R. Mannami, M. Mannami, K. Kitajima, M. Nishi, M. Tamaki, H. Afuso, S. Ito, N. Mituhata

  • Results about, and Algorithms For, Robust Probabilistic Kidney Exchange Matching

    J. Dickerson, A. Procaccia, T. Sandholm

  • Results of a Behavioral Contract Intervention To Improve Adherence and Healthcare Outcomes among Renal Transplant Recipients

    M. Chisholm-Burns, C. Spivey, J. Graff Zivin, J. Lee, E. Sredzinski

  • Results of a Phase 2 Safety, Efficacy, and Pharmacokinetic Study of TOL-101, an Anti-TCR Monoclonal Antibody for the Prophylaxis of Acute Rejection in Kidney Transplantation

    S. Flechner, S. Mulgaonkar, L. Melton, T. Waid, R. Sung, F. Shihab, A. Wiseman, D. Getts

  • Results of Early Corticosteroid Withdrawal under rATG Induction in Hepatitis C Positive Kidney Transplant Recipients: Inferior Yet Improved Outcomes

    M. Aull, J. Guerrero, C. Afaneh, D. Dadhania, J. McDermott, J. Kim, A. Watkins, S. Kapur

  • Results of Response Guided Therapy (RGT) Using Telaprevir in Liver Transplant Recipients with Hepatitis C Virus (HCV) Recurrence: A Single Center Experience of 18 Patients

    P. Mantry, C. Wu, J. Weinstein, A. Mubarak, H. Nazario, A. Mejia, S. Cheng, C. Fasola

  • Retransplantation with or without Graft Nephrectomy. A Single Centre Experience

    C. Puliatti, E. Giorgakis, A. Syed

  • Retroperitoneoscopic Living Donor Nephrectomy Safely Provides Excellent Graft Function

    K. Hotta, K. Morita, H. Harada, N. Fukuzawa, T. Seki, T. Tanabe, H. Sasaki, T. Hirose, D. Iwami, K. Nonomura

  • Revisiting the Second Kidney Transplant in Children

    C. Bell, J. Angelo, J. Bynon, R. Swinford

  • Ribavirin Is Highly Efficient at Treating Chronic Hepatitis-E-Virus Infection in Organ-Transplant-Patients: A Retrospective Multicenter French Study

    N. Kamar, M. Bismuth, S. Hillaire, L. Rostaing, V. Mallet

  • RIP3 Mediated Necroptosis Regulates Cardiac Allograft Inflammation and Survival

    A. Pavlosky, X. Huang, A. Lau, Z. Yin, A. Haig, A. Jevnikar, Z. Zhang

  • Risk Factors Associated with Surgical Complications in Recipients of Kidneys from Very Small Pediatric Donors

    R. Perez, A. Demattos, C. Santhanakrishnan, J. McVicar, M. Gandhi, B. Gallay, D. Adey, M. Alnimri, C. Troppmann

  • Risk Factors for Acute Rejection in Heart Transplanted Recipients

    A. Yusabai, A. Mehrnia, M. Kamgar, M. Sampaio, E. Huang, S. Bunnapradist

  • Risk Factors for Early Hospital Readmission Following Kidney Transplant

    G. Dube, Y. Coppelson, D. Cohen, S. Mohan

  • Risk Factors for Early Onset of Acute Kidney Injury and Subsequent Development of Chronic Renal Disease after Liver Transplantation

    D. Tomescu, M. Popescu, G. Droc, S. Dima, I. Popescu

  • Risk Factors for Graft Failure and Death in Elderly (>65 Years Old) Kidney Transplant Recipients

    A. Faravardeh, B. Bista, M. Eickhoff, S. Jackson, R. Spong, A. Matas, H. Ibrahim

  • Risk Factors for Graft Loss Due to BK Nephropathy: A Paired Kidney Analysis

    J. Gill, S. Hariharan, C. Rose, J. Dong, J. Gill

  • Risk Factors in Venous Thrombosis of Renal Grafts from Deceased Non Heart-Beating Donors

    M. Molina, E. Gonzalez, N. Polanco, L. Garcia-Puente, A. Sevillano, E. Gutierrez, E. Morales, A. Hernandez, J. Morales, A. Andres

  • Risk Factors of Post-Transplant High-Grade CMV Reactivation in CMV-Seropositive Patients in the Modern Immunosuppressive Era

    M. Saito, S. Satoh, K. Numakura, T. Inoue, H. Tsuruta, S. Akihama, N. Tsuchiya, T. Habuchi

  • Risk Factors to Non-Adherence in Kidney Transplantation Patients Applying Triangulation Methodology in a Universal Access Medication Health System

    H. Sanders-Pinheiro, E. Marsicano, N. Fernandes, F. Colugnati, F. Grincencov, N. Fernandes, S. De Geest

  • Risk Factors, Rejection and Infections Associated with Neutropenia in Solid Organ Transplantation: A Retrospective Study

    S. Clairoux, M. Fournier, J. Amiel, M. Tremblay, D. Vinh, C. Coursol, D. Thirion, M. Cantarovich

  • Risk of Recurrence of Pre-Existing Cancer in Organ Recipients

    R. Desai, D. Collett, C. Watson, P. Johnson, T. Evans, J. Neuberger

  • Risk of Transmission of Cancer from Solid Organ Donors in the U.S

    E. Engels

  • Rituximab or Alemtuzumab Induction for ABO Incompatible Renal Transplantation?

    R. Charif, H. De Kort, C. Roufosse, P. Brookes, A. McLean, V. Papalois, N. Hakim, D. Taube, J. Galliford

  • Rituximab To Prevent Renal Allograft Rejection; a Randomized, Double-Blind, Placebo-Controlled Trial

    M. van den Hoogen, E. Steenbergen, A. Hoitsma, L. Hilbrands

  • Robot Assisted Combined Kidney Transplantation and Sleeve Gastrectomy

    S. Ayloo, M. Murphey, P. Giulianotti, E. Benedetti, N. Choudhury, J. Oberholzer

  • Role for DEPTOR in Cell-Intrinsic Mechanisms of Anti-Inflammation in Vascular Endothelial Cells

    S. Bruneau, C. Woda, D. Briscoe

  • Role of 24 Hour Ambulatory Blood Pressure Monitoring after Pediatric Renal Transplantation

    H. Tran, L. Kjelson, P. Grimm, A. Chaudhuri

  • Role of Belatacept (CTLA4-Ig) on B Cells Phenotype in Renal Transplant Recipients

    C. Leibler-Romand, M. Matignon, N. Rouas-Freiss, P. Lang, C. Menier, P. Grimbert

  • Role of Cardiac Rehabilitation after Heart Transplantation in the Reduction of Cardiac Allograft Vasculopathy, The

    M. Kittleson, J. Patel, M. Rafiei, A. Osborne, D. Chang, L. Czer, J. Kobashigawa

  • Role of CD4+CD25+ T reg Cells on Allo-B Cell Formation and DSA Production in a Chronic Rejection Model after T Cell Depletion, The

    J. Kwun, B. Oh, A. Gibby, E. Page, N. Iwakoshi, S. Knechtle

  • Role of Commensal Microbiota in Skin Allograft Rejection

    C. Bartman, Y. Wang, P. Zhou, L. Molinero, M. Alegre

  • Role of Deletion of Donor-Reactive T Cells in Maintaining Human Allograft Tolerance Achieved via Combined Kidney and Bone Marrow Transplantation (CKBMT)

    H. Morris, Y. Shen, T. Kawai, H. Robins, M. Sykes

  • Role of eGFR Equations in Evaluating Deceased Donors for Kidney Transplantation: Sufficient and Appropriate Outcome Markers?

    M. Burdese, M. Priora, M. Messina, M. Tamagnone, G. Daidola, F. Fop, L. Biancone, G. Segoloni

  • Role of Eosinophils in the Induction and Maintenance of the Alloantibody Response, The

    P. Cravedi, D. Lessman, P. Heeger

  • Role of Estimated GFR CKD-EPI as Screening Tool for Donor Selection

    S. Fernandez, S. Mohan, Z. Zaky, J. Crew, G. Dube, J. Wexler, M. Carrol, L. Ratner, D. Cohen, B. Tanriover

  • Role of Foxp3 for Augmented Homeostatic Proliferation of Treg, The

    Y. Lin, D. Rothstein

  • Role of Graft Non-Hematopoietic Cells in Organ Transplant Tolerance, The

    M. Morita, J. Qin, K. Brown, C. Miller, J. Fung, L. Lu, S. Qian

  • Role of Graft-Derived MCP1 in Antibody-Mediated Rejection of Cardiac Allografts

    T. Abe, C. Su, S. Iida, W. Baldwin III, N. Nonomura, S. Takahara, R. Fairchild

  • Role of Immunoglobulin (Ig)-G Subclasses and C1q in De Novo HLA DQ DSA Kidney Transplant Outcomes, The

    M. Freitas, L. Rebellato, M. Ozawa, A. Nguyen, M. Everly, N. Sasaki, P. Terasaki

  • Role of Immunosuppression on Hyperuricemia and Proteinuria Affecting Graft Survival, The

    U. Cakir, I. Berber, E. Gurluler, N. Gures, A. Alim, A. Gurkan

  • Role of Increased Autophagic Flux in Renal Tubular Epithelial Cells Undergoing Warm Reperfusion (WR) after Cold Ischemia (CI), The

    A. Jani, S. Jain, T. Nydam, C. Edelstein

  • Role of Innate and Adaptive Immunity in Survival and Neurogenesis of Neural Progenitor Cell Grafts, The

    L. Phillips, S. Krams, T. Palmer, O. Martinez

  • Role of Interleukin-33/ST2 Pathway in Hepatic Ischemia/Reperfusion Injury, The

    H. Huang, H. Chen, A. Tsung

  • Role of IV Acetaminophen (APAP) in Reducing Narcotic Use in Live Donor Nephrectomy, The

    M. Tan, T. Ommert, R. Cross, M. Mulloy, S. D'Annunzio, M. Johnson, H. Pollinger

  • Role of Mannose Binding Lectin on the Incidence of Rejection after Kidney and Other Solid Organ Transplantation

    D. Golshayan, A. Wojtowicz, O. Manuel, S. Bibert, M. Pascual, P. Meylan, P. Bochud

  • Role of Microcirculatory Integrity in DCD Ex-Vivo Organ Perfusion

    Q. Liu, A. Nassar, K. Farias, C. Tom, A. Bennett, G. D'Amico, K. Abu-Elmagd, J. Fung, C. Miller, C. Quintini

  • Role of PI3K/AKT and Autophagy in the Protective Effect of Fasting Against Liver Ischemia Reperfusion Injury in Mice, The

    G. Li, J. Rao, J. Qin, L. Lu, X. Wang

  • Role of Single-Port Laparoscopy in Donor Right Hepatectomy for Living Donor Liver Transplantation

    Y. You, H. Choi, G. Na, J. Han, E. Kim, S. Lee, T. Hong, Y. Yoon, S. Kim, D. Kim

  • Role of Soluble FGL2 in Renal Ischemia Reperfusion Injury in a Porcine Auto-Transplantation Model

    Z. Zhao, C. Yang, L. Li, T. Zhao, R. Rong, M. Xu, B. Yang, T. Zhu

  • Role of the Alternative Pathway of Complement in Ischemia/Reperfusion and Chronic Graft Injury in a Mouse Model of Kidney Allograft

    R. Cavinato, N. Azzollini, F. Casiraghi, M. Todeschini, S. Aiello, G. Remuzzi, M. Noris

  • Routine Use of Microsurgical Techniques To Minimize Hepatic Arterial Complications in 342 Consecutive Living Donor Liver Transplants

    K. Asonuma, S. Hayashida, M. Honda, T. Takeichi, H. Yamamoto, K. Lee, Y. Ohya, T. Murokawa, Y. Inomata

Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences